PACLITAXEL 100 mg/20mL
PACLITAXEL · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · Mylan Institutional LLC
PACLITAXEL is a injection, powder, lyophilized, for suspension containing paclitaxel at 100 mg/20mL, taken intravenous. Manufactured by Mylan Institutional LLC.
Key Facts
- Brand Name
- PACLITAXEL
- Generic Name
- PACLITAXEL
- NDC Code (Product)
67457-937- Manufacturer
- Mylan Institutional LLC
- Strength
- 100 mg/20mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA217877
- Drug Class
- Microtubule Inhibitor [EPC]
- Marketing Start
- 10/09/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is PACLITAXEL used for?
PACLITAXEL contains PACLITAXEL. It is a injection, powder, lyophilized, for suspension taken intravenous. Consult your doctor for specific uses.
Is PACLITAXEL a controlled substance?
PACLITAXEL is not classified as a controlled substance by the DEA.
What is the generic name for PACLITAXEL?
The generic name for PACLITAXEL is PACLITAXEL. There are 12 other brand versions of PACLITAXEL.
What is the NDC code for PACLITAXEL 100 mg/20mL?
The NDC (National Drug Code) for PACLITAXEL 100 mg/20mL is 67457-937, listed by Mylan Institutional LLC.
Other Paclitaxel Brands
See all →- Paclitaxel100 mg/20mL0480-3290
- Paclitaxel6 mg/mL0703-3216
- Paclitaxel6 mg/mL0703-3217
- PACLITAXEL PACLITAXEL6 mg/mL23155-882
- Paclitaxel6 mg/mL61703-342
- Paclitaxel6 mg/mL68001-705
- Paclitaxel100 mg/100mg75007-041
- Paclitaxel6 mg/mL46708-622
- PACLITAXEL PACLITAXEL6 mg/mL68083-179
- Paclitaxel protein-bound particles100 mg/20mL69097-398
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)